Breast Cancer Therapeutics Market Size And Share

  • Report Code : TIPRE00030059
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 204
Buy Now

Breast Cancer Therapeutics Market Size, Top Players, and Forecast by 2030

Buy Now

Breast Cancer Therapeutics Market Report Breast Cancer Therapeutics Market Scope and Analysis Breast Cancer Therapeutics Market Size and Share

Breast Cancer Therapeutics Market: Strategic Insights

Breast Cancer Therapeutics Market

  • CAGR (2022 - 2030)
    9.4%
  • Market Size 2022
    US$ 31.07 Billion
  • Market Size 2030
    US$ 63.97 Billion

Market Dynamics

GROWTH DRIVERS
  • Growing Burden of Breast Cancers
  • Launch of Several Diagnostics and Screening Programs
FUTURE TRENDS
  • Increasing Use of Personalized Medicine
OPPORTUNITIES
  • Increased Support From The Government and Private Organizations

Key Players

  • Eli Lilly and Co
  • Eisai Co Ltd
  • Novartis AG
  • AstraZeneca Plc
  • Pfizer Inc
  • Gilead Sciences Inc
  • Merck Co Inc
  • Genentech Inc
  • Teva Pharmaceutical Industries Ltd

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Drug Therapy
  • Targeted Drug Therapy
  • Hormonal Drug Therapy
  • Chemotherapy
  • Immunotherapy/Biological Therapy
Breast Cancer Type
  • Hormone Receptor
  • HER2+
  • Triple-Negative Breast Cancer
Distribution Channel
  • Hospital Pharmacies
  • Drug Stores and Retail Pharmacies
  • Online Pharmacies